<?xml version="1.0" encoding="UTF-8"?>
<p>The second model, the decentralized CAR-T Unit, is a model suitable for entities where the infusion of cell therapies occurs under the responsibility of different subjects. This model is implemented in complex organizational structures in which the types of IECs utilized for cell therapy are different and are administered to patients with either blood malignancies or solid tumors (
 <xref ref-type="fig" rid="f2">
  <bold>Figure 2</bold>
 </xref>). This model is useful in Hospitals and Institutes with separate business units for Oncology and Hematology even within a single CAR-T center. This is useful for the current different values of Oncology and Hematology and the continuous evolution of their relationship. Furthermore, this model allows having a CAR-T unit even in the context of subdomain of Oncology, such as Neuroncology.
</p>
